Harrington, R.A.

patient trial infarction event death elevation study treatment ck-mb outcome intervention syndrome /iiia mortality pursuit 30 days angina eptifibatide investigator heart glycoprotein group platelet therapy percutaneou table stroke baseline ratio placebo heparin creatine result circulation model disease aspirin analysis month level st-segment elevation st-segment 6- month mortality thrombocytopenia characteristic 30- effect revascularization artery epti fibatide randomized difference baseline characteristics end point surgery signi category population receptor kinase point strategy procedure enzyme reduction 6 months predictor end-point hospital fibatide ischemic pursuit trial infusion america definition cardiol committee history variable incidence